In this Jan. 27, 2016, file photo, an Aedes aegypti mosquito known to carry the Zika virus, is photographed through a microscope at the Fiocruz institute in Recife, Pernambuco state, Brazil. (AP Photo/Felipe Dana, File)
Genetically modified mosquitoes are being released in the Florida Keys in an effort to combat persistent insect-borne diseases such as Dengue fever and the Zika virus.
The Florida Keys Mosquito Control District and the Oxitec biotechnology company announced Thursday that release boxes, non-release boxes and netted quality control boxes are being placed this week in six locations: two on Cudjoe Key, one on Ramrod Key and three on Vaca Key.
Starting early next month, less than 12,000 mosquitoes are expected to emerge each week for approximately 12 weeks. Untreated comparison sites will be monitored with mosquito traps on Key Colony Beach, Little Torch Key and Summerland Key.
“We really started looking at this about a decade ago, because we were in the middle of a dengue fever outbreak here in the Florida Keys,” Florida Keys Mosquito Control District executive director Andrea Leal said during a video news conference. “So we’re just very excited to move forward with this partnership, working both with Oxitec and members of the community.”
Keys officials approved the pilot project last year involving the striped-legged Aedes aegypti mosquito, which is not native to Florida. The insect transmits several diseases to humans, particularly in the Keys island chain where dozens of cases of dengue fever were reported last year.
Oxitec’s non-biting male mosquitoes are expected to mate with the local biting female mosquitoes. The female offspring of these encounters cannot survive, controlling the Aedes aegypti population. The Aedes aegypti mosquito makes up about 4% of the mosquito population in the Keys but is responsible for virtually all mosquito-borne diseases transmitted to humans. This mosquitoes transmit dengue, Zika, yellow fever and other human diseases, and can transmit heartworm and other potentially deadly diseases to pets and other animals.
An earlier version of the genetically-modified mosquitoes was used in Brazil, but this is the first time they have been used in the United States.
“We’re an organization comprised of very passionate individuals working to develop solutions that can have a public health impact,” Oxitec CEO Grey Frandsen said. “We have people living in the Keys. We have spent a huge amount of time engaging with residents, with community leaders, with small businesses, and have seen the results of that.”
Some people worry about using genetically-modified organisms, or GMOs, that they believe could alter the planet’s natural balance. Barry Wray, director of the Florida Keys Environmental Coalition, has said that officials have no idea what the insects will do.
It’s also unclear whether the genetically-modified mosquitoes will be able to accomplish their intended task, said Max Moreno, an expert in mosquito-borne diseases at Indiana University who is not involved in the company or the pilot project. Moreno has said the lab-created males might have a difficult time competing with rivals that have gone through the natural selection process, in which only the fittest survive and mate.
The genetically-modified mosquitoes have been approved by the Environmental Protection Agency and the Florida Department of Agriculture and Consumer Services, officials said. It also has support from the U.S. Centers for Disease Control and Prevention. The project is being funded by Oxitec.
2021 was an exciting year for space innovations, but 2022 could hold even more in store. Cheddar took a deep dive into the space mission on tap for the year ahead.
The United States purchased over 600,000 doses of a monoclonal antibody treatment from Glaxosmithkline and Vir Biotechnology, bringing the total worldwide doses purchased to 1.7 million. This comes as the country attempts to ramp up treatment options as cases of the omicron variant continue to surge. Dr. Asha Shah, Director of Infectious Diseases at Stamford Health joined Cheddar's Opening Bell to discuss.
As the pandemic slammed the brakes on the nation's economy in 2020, America's greenhouse gas emissions reached their lowest levels in at least three decades. However, as the world, and the economy re-opened, 2021 told a much different story as emissions surged. Biden's flagship 'Build Back Better' act involves billions in spending on electric cars and renewables, in an effort to cut U.S. emissions, experts are still skeptical that the nation will meet the current 2030 target. Andrew Dessler, professor of atmospheric sciences at Texas A&M University, joins Cheddar News.
Amid the omicron surge, a new debate has emerged about whether or not throat swabs are more effective than nasal swabs for COVID testing. Dr. William Schaffner, MD, professor of infectious diseases, Vanderbilt Medical Center, sat down with Cheddar's News Wrap to weigh in on the dispute. "Should there be a change? You've got to do the studies, show that in the field [a throat swab] works as well or better than the nasal specimen," he said. "Let's not do it off our hips, as we say."
Virginia Governor Ralph Northam is declaring a state of emergency after Monday's winter storm left hundreds of drivers stranded on the interstate for more than 24 hours.
The snow also knocked out power for many residents, with more than 100,000 outages remaining days later.
Michael Wehner, a climate scientist at Lawrence Berkeley national laboratory, discusses recent weather disasters.
As the need for COVID-19 testing increases, so does the price of the tests themselves. An agreement with The White House and several major companies to sell the tests at a lower cost has now expired, sending prices up as retailers struggle to keep kits on shelves. Dr. Thomas McGinn, executive VP of physician enterprise at Common Spirit Health, joins Cheddar News to discuss.
A new report shows 2021 saw a surge in U.S. greenhouse gas emissions, indicating that the country remains far off track from meeting President Biden's climate change targets. Biden previously pledged to cut the nation's emissions in half by 2030, and now experts warn that immediate action must be taken in order to get the nation back on track. Zeke Hausfather, director of climate and energy at The Breakthrough Institute on U.S. Emissions and Global Temperatures, joins Cheddar News to discuss.
Electric vehicles are quickly becoming an accessible way for consumers to slash emissions as legacy automakers begin to electrify their fleets and world leaders including President Joe Biden push for broad EV adoption. But consumers have concerns about EV range, the availability of charging stations, and more. What if it were both helpful to consumers — and feasible from a climate change standpoint — to keep hybrid models that run on gas on the market? Gill Pratt, CEO of the Toyota Research Institute & Toyota Motor Corporation's Chief Scientist joins Cheddar Climate to discuss his team's research about 'carbon return on investment,' how Toyota is electrifying its fleet, and more.
According to a recent analysis compiled by The Washington Post, more than four in 10 Americans lived in areas hit by climate-related disasters in 2021. Jonathan Porter, Chief Meteorologist at AccuWeather, joined Cheddar Climate to discuss what this means and what can be done to prevent severe weather events from becoming even worse.
It's a painfully cold week across a large portion of the U.S. with more than 185 million Americans experiencing below-freezing temperatures on Monday and 10 million of them dealing with dangerous sub-zero temps.
